ERBB2 and breast cancer: However, in the subgroup analysis, SPINT2 was correlated with poorer DMFS in particular types, specifically in patients with luminal A, luminal B, and HER2−, which implied that SPINT2 was possibly involved in metastasis in particular subtypes, thus rendering adverse outcomes in breast cancer patients.